BioNxt Solutions Inc.

CNSX:BNXT Stock Report

Market Cap: CA$92.6m

BioNxt Solutions Management

Management criteria checks 2/4

BioNxt Solutions' CEO is Hugh A. Rogers, appointed in Nov 2024, has a tenure of 7.92 years. total yearly compensation is CA$189.31K, comprised of 95.1% salary and 4.9% bonuses, including company stock and options. directly owns 0.8% of the company’s shares, worth CA$742.90K. The average tenure of the management team and the board of directors is 1 years and 6.9 years respectively.

Key information

Hugh A. Rogers

Chief executive officer

CA$189.3k

Total compensation

CEO salary percentage95.08%
CEO tenure1yr
CEO ownership0.8%
Management average tenure1yr
Board average tenure6.9yrs

Recent management updates

Why We Think BioNxt Solutions Inc.'s (CSE:BNXT) CEO Compensation Is Not Excessive At All

Oct 27
Why We Think BioNxt Solutions Inc.'s (CSE:BNXT) CEO Compensation Is Not Excessive At All

Recent updates

Why We Think BioNxt Solutions Inc.'s (CSE:BNXT) CEO Compensation Is Not Excessive At All

Oct 27
Why We Think BioNxt Solutions Inc.'s (CSE:BNXT) CEO Compensation Is Not Excessive At All

BioNxt Solutions (CSE:BNXT) Is Making Moderate Use Of Debt

Nov 30
BioNxt Solutions (CSE:BNXT) Is Making Moderate Use Of Debt

CEO Compensation Analysis

How has Hugh A. Rogers's remuneration changed compared to BioNxt Solutions's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025n/an/a

-CA$6m

Mar 31 2025n/an/a

-CA$6m

Dec 31 2024CA$189kCA$180k

-CA$5m

Sep 30 2024n/an/a

-CA$6m

Jun 30 2024n/an/a

-CA$6m

Mar 31 2024n/an/a

-CA$8m

Dec 31 2023CA$189kCA$180k

-CA$8m

Sep 30 2023n/an/a

-CA$13m

Jun 30 2023n/an/a

-CA$13m

Mar 31 2023n/an/a

-CA$12m

Dec 31 2022CA$240kCA$231k

-CA$12m

Sep 30 2022n/an/a

-CA$14m

Jun 30 2022n/an/a

-CA$14m

Mar 31 2022n/an/a

-CA$17m

Dec 31 2021CA$225kCA$216k

-CA$21m

Sep 30 2021n/an/a

-CA$15m

Jun 30 2021n/an/a

-CA$19m

Mar 31 2021n/an/a

-CA$19m

Dec 31 2020CA$180kCA$180k

-CA$17m

Sep 30 2020n/an/a

-CA$16m

Jun 30 2020n/an/a

-CA$13m

Mar 31 2020n/an/a

-CA$10m

Dec 31 2019CA$180kCA$180k

-CA$8m

Sep 30 2019n/an/a

-CA$6m

Jun 30 2019n/an/a

-CA$2m

Mar 31 2019n/an/a

-CA$2m

Dec 31 2018CA$155kCA$155k

-CA$861k

Compensation vs Market: Hugh A.'s total compensation ($USD134.96K) is about average for companies of similar size in the Canadian market ($USD160.39K).

Compensation vs Earnings: Hugh A.'s compensation has increased whilst the company is unprofitable.


CEO

Hugh A. Rogers (45 yo)

1yr
Tenure
CA$189,305
Compensation

Mr. Hugh A. D. Rogers, B.Sc., LL B had been the Chief Executive Officer at Coronado Resources Ltd. since March 6, 2015 until October 2017.Mr. Rogers served as the Chairman of the Board at Telo Genomics Co...


Leadership Team

NamePositionTenureCompensationOwnership
Hugh A. Rogers
Co-Founder1yrCA$189.31k0.80%
CA$ 742.9k
Raimar Lobenberg
Co-Founder & Directorno datano data4.14%
CA$ 3.8m
Wolfgang Probst
Co-Founder1yrCA$177.82k1.11%
CA$ 1.0m
Florian Sahr
Head of Project Management3.4yrsno datano data
Wolfgang Wagner
Head of Research & Developmentno datano datano data
1.0yrs
Average Tenure
45yo
Average Age

Experienced Management: BNXT's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Hugh A. Rogers
Co-Founder7.9yrsCA$189.31k0.80%
CA$ 742.9k
Raimar Lobenberg
Co-Founder & Director6.9yrsno data4.14%
CA$ 3.8m
Wolfgang Probst
Co-Founder6.9yrsCA$177.82k1.11%
CA$ 1.0m
Patrick Meagher
Director2.2yrsCA$90.00k0.038%
CA$ 35.0k
David Waterhouse
Directorless than a yearno data0.016%
CA$ 15.2k
6.9yrs
Average Tenure
44.5yo
Average Age

Experienced Board: BNXT's board of directors are considered experienced (6.9 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/14 14:57
End of Day Share Price 2025/11/14 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioNxt Solutions Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.